Loading candles…
Symbiotec Pharmalab Limited, incorporated on September 20, 2002, is a pharmaceutical and biotechnology company based in Indore, Madhya Pradesh, India. The company specializes in the development and manufacturing of active pharmaceutical ingredients (APIs), particularly corticosteroids and steroidal hormones, serving both domestic and international markets. Symbiotec operates two manufacturing facilities in Indore, with a combined chemical synthesis capacity of 584.67 metric tonnes and fermentation capacity of 300 kilolitres. The company holds approvals from global regulatory bodies, including the US FDA and EU-GMP. As of June 30, 2025, Symbiotec employed approximately 1,822 individuals. The company's authorized share capital is ₹30 crore, with a paid-up capital of ₹12.34 crore.
This page is a live market overview for SYMBIOTEC PHARMALAB LTD (SYMBIOTEC) on the NSE. As a listed security, SYMBIOTEC PHARMALAB LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SYMBIOTEC before placing trades on tick2trade.
As of the latest feed, SYMBIOTEC last traded at ₹1,024.05 on NSE, up ₹0 (0.00%) from the previous close of ₹1,024.05. Today's session range is ₹0 – ₹0, against a 52-week band of ₹934.2 – ₹1,193.7. Traded volume today stands at 5.47L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SYMBIOTEC in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SYMBIOTEC is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SYMBIOTEC PHARMALAB LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SYMBIOTEC. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SYMBIOTEC option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 21 Sep 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.